Lucid Diagnostics Inc.
LUCD
$1.26
-$0.02-1.56%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.13% | 20.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.13% | 20.08% | |||
| Cost of Revenue | 24.88% | 4.34% | |||
| Gross Profit | -76.95% | 19.75% | |||
| SG&A Expenses | 2.57% | 3.68% | |||
| Depreciation & Amortization | 111.43% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.72% | 5.74% | |||
| Operating Income | -4.98% | -4.49% | |||
| Income Before Tax | 6.71% | -12.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.71% | -12.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.71% | -12.41% | |||
| EBIT | -4.98% | -4.49% | |||
| EBITDA | -5.01% | -4.71% | |||
| EPS Basic | 19.50% | -7.58% | |||
| Normalized Basic EPS | 44.34% | -0.21% | |||
| EPS Diluted | 19.50% | -7.58% | |||
| Normalized Diluted EPS | 44.34% | -0.21% | |||
| Average Basic Shares Outstanding | 15.89% | 4.48% | |||
| Average Diluted Shares Outstanding | 15.89% | 4.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||